Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Hemangiomas and Vascular Malformations in Infants and Children
3.286
Zitationen
2
Autoren
1982
Jahr
Abstract
Forty-nine specimens from a variety of vascular lesions were analyzed for cellular characteristics. Two major categories of lesions emerged from this investigation: hemangiomas and vascular malformations. This classification and its implications are justified by several considerations. Hemangiomas in the proliferating phase (n = 14) were distinguished by (1) endothelial hyperplasia with incorporation of [3H]thymidine, (2) multilaminated basement membrane formation beneath the endothelium, and (3) clinical history of rapid growth during early infancy. Hemangiomas in the involuting phase (n = 12) exhibited (1) histologic fibrosis and fat deposition, (2) low to absent [3H]thymidine labeling of endothelial cells, and (3) rapid growth and subsequent regression. The endothelium in hemangiomas had many characteristics of differentiation: Weibel-Palade bodies, alkaline phosphatase, and factor VIII production. Vascular malformations (n = 23) demonstrated no tritiated thymidine incorporation and normal ultrastructural characteristics. These lesions were usually noted at birth, grew proportionately with the child, and consisted of abnormal, often combined, capillary, arterial, venous, and lymphatic vascular elements. This cell-oriented analysis provides a simple yet comprehensive classification of vascular lesions of infancy and childhood and serves as a guide for diagnosis, management, and further research.
Ähnliche Arbeiten
Propranolol for Severe Hemangiomas of Infancy
2008 · 2.323 Zit.
HEMANGIOPERICYTOMA A VASCULAR TUMOR FEATURING ZIMMERMANNʼS PERICYTES
1942 · 1.440 Zit.
Lymphangiogenesis: Molecular Mechanisms and Future Promise
2010 · 1.428 Zit.
Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies
2015 · 1.356 Zit.
Recurrent BRAF mutations in Langerhans cell histiocytosis
2010 · 1.218 Zit.